On this episode, we discuss some of the new medications that were FDA approved in the first half of 2024. We discuss pivmecillinam (Pivya), ceftobiprole medocaril sodium (Zevtera), vadadustat (Vafseo), sotatercept (Winrevair), aprocitentan (Tryvio), cefepime/enmetazobactam (Exblifep), and more.

Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website:

https://www.freece.com/

If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast.

Thanks for listening!

We want to give a big thanks to our sponsor, High-Powered Medicine. HPM is a book/website database of summaries for over 150 landmark clinical trials. You can get a copy of HPM, written by Dr. Alex Poppen, PharmD, at the links below:

Purchase a subscription or PDF copy - https://highpoweredmedicine.com/

Purchase the paperback and hardcover - Barnes and Noble website

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

www.pyrls.com/corconsultrx

If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com
Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

New Drugs of 2024 *ACPE-Accredited*

CorConsult Rx: Evidence-Based Medicine and Pharmacy

New Drugs of 2024 *ACPE-Accredited*

New Drugs of 2024 ACPE-Accredited

New Drugs of 2024 ACPE-Accredited